Indication
For the treatment of Wilson's disease in adults, adolescents and children ≥ 5 years intolerant to D-penicillamine therapy.

Medicine details

Medicine name:
trientine tetrahydrochloride (Cuprior)
SMC ID:
SMC2222
Pharmaceutical company
GMP-Orphan United Kingdom Ltd
BNF chapter
Nutrition and blood
Submission type
Abbreviated
Status
Publication due date:
11 November 2019
SMC meeting date:
01 October 2019